You have 9 free searches left this month | for more free features.

Pharmaceutical Solutions

Showing 1 - 25 of 3,362

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

SARS-CoV-2, COVID-19, Mouthwashes Trial in Jeddah (Distilled Water, 1% Povidone Iodine (PVP-I), 1.5% Hydrogen Peroxide (H2O2))

Completed
  • SARS-CoV-2
  • +7 more
  • Distilled Water
  • +5 more
  • Jeddah, Saudi Arabia
    Alhamra TETAMMAN clinic (PHC)
Jul 18, 2022

Infertility, Female Trial in Cairo (Epifasi: Human chorionic gonadotrophin, Pregnyl: Human chorionic gonadotrophin)

Completed
  • Infertility, Female
  • Epifasi: Human chorionic gonadotrophin
  • Pregnyl: Human chorionic gonadotrophin
  • Cairo, Egypt
    Genuine Research Center GRC
Oct 22, 2020

Women Exposed to Rimegepant During Pregnancy

Active, not recruiting
  • Migraine
  • Research Triangle Park, North Carolina
    Research Triangle Institute d/b/a RTI Health Solutions
Feb 24, 2022

Graft Failure Trial in Australia, Canada, Israel (Emapalumab)

Terminated
  • Graft Failure
  • Melbourne, Australia
  • +4 more
Jul 25, 2022

Hepatic Ascites Trial in Shibin Al Kawm (Oral standard diuretics therapy, Hypertonic saline solution, Etilefrine)

Completed
  • Hepatic Ascites
  • Oral standard diuretics therapy
  • +2 more
  • Shibīn Al Kawm, Menoufiya, Egypt
    National liver institute- menoufiya university
Mar 2, 2021

Pulmonary Hypertension, COPD Trial in United States (Inhaled NO delivered via INOpulse DS-C Device, Placebo delivered via

Completed
  • Pulmonary Hypertension
  • Chronic Obstructive Pulmonary Disease
  • Inhaled NO delivered via INOpulse DS-C Device
  • Placebo delivered via INOpulse DS-C Device
  • Jasper, Alabama
  • +42 more
Jul 13, 2022

Migraine, With or Without Aura Trial in United States (Rimegepant)

Completed
  • Migraine, With or Without Aura
  • Birmingham, Alabama
  • +97 more
Dec 15, 2022

Dyslipidemias Trial in Australia, New Zealand (ARO-APOC3)

Enrolling by invitation
  • Dyslipidemias
  • Beverly Hills, California
  • +36 more
Jan 13, 2023

Acute Migraine Trial in United States (Vazegepant (BHV-3500))

Completed
  • Acute Migraine
  • Vazegepant (BHV-3500)
  • Huntsville, Alabama
  • +66 more
Feb 1, 2022

Alzheimer, Mild Cognitive Impairment Trial in United States (Florbetapir F 18 PET Scan)

Active, not recruiting
  • Alzheimer Disease
  • Mild Cognitive Impairment
  • Florbetapir F 18 PET Scan
  • Anaheim, California
  • +76 more
Sep 21, 2022

Osteoarthritis, Knee, Osteoarthritis, Hip Trial in Worldwide (Fasinumab, Naproxen, Fasinumab-matching )

Completed
  • Osteoarthritis, Knee
  • Osteoarthritis, Hip
  • Mesa, Arizona
  • +138 more
Oct 18, 2022

Hydration Trial in Kent (Control Group, Oral Rehydration Solution 1, Oral Rehydration Solution 2)

Recruiting
  • Hydration
  • Control Group
  • +3 more
  • Kent, Ohio
    Kent State University
Dec 14, 2022

Metabolic Ketoacidosis, Ketoacidemia, Acetonemia Trial in Tunis (Sodium chloride 0.9% (SC), Ringer lactate (RL))

Recruiting
  • Metabolic Ketoacidosis
  • +3 more
  • Sodium chloride 0.9% (SC)
  • Ringer lactate (RL)
  • Tunis, Tunisia
    Ahlem Trifi
Apr 11, 2023

Presbyopia, Near Vision, Miosis Trial in China (Aceclidine+Brimonidine combination ophthalmic solution, Aceclidine ophthalmic

Not yet recruiting
  • Presbyopia
  • +3 more
  • Aceclidine+Brimonidine combination ophthalmic solution
  • +2 more
  • Wenzhou, Zhejiang, China
  • +18 more
Sep 19, 2023

Esophageal Squamous Cell Carcinoma Trial in China (1% Lugol's iodine solution, 5% Lugol's iodine solution)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • 1% Lugol's iodine solution
  • 5% Lugol's iodine solution
  • Ankang, Shaanxi, China
  • +5 more
Sep 25, 2023

Post-SOPHrology Cancer Patients' anxieTY Report

Terminated
  • Cancer
  • Questionnaires
  • Saint-Priest-en-Jarez, France
    Institut de Cancérologie Lucien Neuwirth
Feb 7, 2022

Presbyopia, Near Vision, Miosis Trial in Chandler, Glendale (Aceclidine+Brimonidine combination ophthalmic solution, Placebo,

Recruiting
  • Presbyopia
  • +3 more
  • Aceclidine+Brimonidine combination ophthalmic solution
  • +2 more
  • Chandler, Arizona
  • +1 more
Mar 2, 2023

Androgenetic Alopecia Trial in East Melbourne, Pascoe Vale South (prostaglandin F2a analogue in vehicle solution high dose,

Recruiting
  • Androgenetic Alopecia
  • prostaglandin F2a analogue in vehicle solution high dose
  • +3 more
  • East Melbourne, Victoria, Australia
  • +1 more
Dec 20, 2022

Heart Transplantation Trial in Berlin, Gießen, München (Custodiol-N, Custodiol)

Active, not recruiting
  • Heart Transplantation
  • Berlin, Germany
  • +2 more
Sep 8, 2023

Hepatic Encephalopathy Trial (Branched-chain amino acids (BCAA), enriched solution (Aminoleban) and L-ornithine L-aspartate

Not yet recruiting
  • Hepatic Encephalopathy
  • Branched-chain amino acids (BCAA), enriched solution (Aminoleban) and L-ornithine L-aspartate (LOLA)
  • Branched-chain amino acids (BCAA), enriched solution (Aminoleban)
  • (no location specified)
Sep 9, 2022

Fatty Liver Trial in United States (Group 1 NRPT, Group 2 NRPT, Group 3 Placebo)

Completed
  • Fatty Liver
  • Group 1 NRPT
  • +2 more
  • Hialeah, Florida
  • +8 more
Oct 23, 2020

Sepsis, Septic Shock, Shock, Toxic Trial in Manchester (hyperoncotic human albumin solution, Buffered crystalloid solutions)

Not yet recruiting
  • Sepsis
  • +2 more
  • hyperoncotic human albumin solution
  • Buffered crystalloid solutions
  • Manchester, Lancashire, United Kingdom
  • +1 more
Jul 5, 2022

Spinal Diseases Trial (Desflurane Inhalation Solution, Sevoflurane Inhalation Solution)

Not yet recruiting
  • Spinal Diseases
  • Desflurane Inhalation Solution
  • Sevoflurane Inhalation Solution
  • (no location specified)
Nov 7, 2023